All lobbying filings

LMH STRATEGIC SOLUTIONS

LMH STRATEGIC SOLUTIONS filed a Q2 report for AVADEL PHARMACEUTICALS, PLC on July 5, 2026, reporting $60,000 in lobbying income.

Lobbying for AVADEL PHARMACEUTICALS, PLC · Biopharmaceutical company.

All filings by LMH STRATEGIC SOLUTIONS · Everything AVADEL PHARMACEUTICALS, PLC has reported

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Oct 19, 2026.

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 5, 2026

Income

$60,000

What the client paid this registrant for the period.

Official filing document

Lobbyists on this filing 1

ALANNA TEMME

Previously held: Legislative Director, U.S. Representative Jon Porter

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Prescription Drug Competition Issues. H.R.4692/S.574 - Increasing Prescription Drug Competition Act. VA Appropriations Request.

Bills named in this filing 2

H.R. 4692
Increasing Prescription Drug Competition Act
S. 574
Increasing Prescription Drug Competition Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.